1.74
전일 마감가:
$1.74
열려 있는:
$1.74
하루 거래량:
304.19K
Relative Volume:
0.50
시가총액:
$70.90M
수익:
$68.68M
순이익/손실:
$-60.84M
주가수익비율:
-1.0875
EPS:
-1.6
순현금흐름:
$-38.42M
1주 성능:
+1.75%
1개월 성능:
+6.10%
6개월 성능:
-78.75%
1년 성능:
-74.93%
풀몬스 Stock (LUNG) Company Profile
명칭
Pulmonx Corp
전화
650-364-0400
주소
700 CHESAPEAKE DRIVE, REDWOOD CITY
LUNG을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
LUNG
Pulmonx Corp
|
1.74 | 70.90M | 68.68M | -60.84M | -38.42M | -1.60 |
![]()
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
풀몬스 Stock (LUNG) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-31 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2025-03-10 | 개시 | D. Boral Capital | Buy |
2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-06-04 | 개시 | Lake Street | Buy |
2024-02-23 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2023-09-05 | 개시 | Craig Hallum | Buy |
2023-02-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2023-01-03 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-03-02 | 재개 | BofA Securities | Neutral |
2021-12-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2021-04-01 | 개시 | Citigroup | Buy |
2021-03-25 | 개시 | Piper Sandler | Neutral |
2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-10-26 | 개시 | BofA Securities | Buy |
2020-10-26 | 개시 | Canaccord Genuity | Buy |
2020-10-26 | 개시 | Morgan Stanley | Equal-Weight |
2020-10-26 | 개시 | Stifel | Buy |
2020-10-26 | 개시 | Wells Fargo | Equal Weight |
모두보기
풀몬스 주식(LUNG)의 최신 뉴스
Real time pattern detection on Pulmonx Corporation stock2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Chart based analysis of Pulmonx Corporation trends2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges By Investing.com - Investing.com South Africa
Pulmonx Corporation Reaches Critical Trendline SupportWeekly Risk Summary & Safe Swing Trade Setup Alerts - beatles.ru
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com
Will Pulmonx Corporation stock recover after recent dropJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Using R and stats models for Pulmonx Corporation forecastingJuly 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
Pattern recognition hints at Pulmonx Corporation upsideSell Signal & High Return Stock Watch Alerts - Newser
Will Pulmonx Corporation bounce back from current supportJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
Pulmonx Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Will breakout in Pulmonx Corporation lead to full recoveryJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Backtesting results for Pulmonx Corporation trading strategiesMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
How to build a custom watchlist for Pulmonx CorporationWeekly Profit Summary & Weekly High Potential Stock Alerts - Newser
Using data tools to time your Pulmonx Corporation exitJuly 2025 Institutional & Verified Short-Term Plans - Newser
How to track smart money flows in Pulmonx Corporation2025 Market Overview & Verified Swing Trading Watchlists - Newser
What data driven models say about Pulmonx Corporation’s future2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
What Fibonacci levels say about Pulmonx Corporation reboundJuly 2025 Retail & Growth Focused Stock Reports - Newser
What are the future prospects of Pulmonx CorporationMarket Volume Report & Long-Term Safe Investment Plans - khodrobank.com
Can trapped investors hope for a rebound in Pulmonx Corporation2025 Price Momentum & Consistent Growth Stock Picks - Newser
Does Pulmonx Corporation fit your quant trading model2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser
How sentiment analysis helps forecast Pulmonx CorporationCPI Data & Weekly Return Optimization Plans - Newser
Is Pulmonx Corporation meeting your algorithmic filter criteriaTrade Performance Summary & AI Optimized Trade Strategies - Newser
Trend analysis for Pulmonx Corporation this weekQuarterly Trade Review & Technical Pattern Based Buy Signals - Newser
Is it time to cut losses on Pulmonx CorporationVolume Spike & Daily Volume Surge Signals - Newser
How to escape a deep drawdown in Pulmonx Corporation2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Real time alert setup for Pulmonx Corporation performanceTrade Ideas & Stepwise Trade Signal Implementation - Newser
Pulmonx (NASDAQ:LUNG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Applying big data sentiment scoring on Pulmonx CorporationJuly 2025 Levels & Reliable Entry Point Alerts - Newser
Published on: 2025-08-29 19:26:58 - Newser
풀몬스 (LUNG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
풀몬스 주식 (LUNG) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Joshi Mehul | Chief Financial Officer & PAO |
Sep 02 '25 |
Sale |
1.60 |
7,936 |
12,698 |
208,489 |
Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Sep 02 '25 |
Sale |
1.60 |
6,543 |
10,469 |
379,788 |
Lehman David Aaron | GENERAL COUNSEL |
Sep 02 '25 |
Sale |
1.60 |
9,769 |
15,630 |
263,270 |
Ferrari Richard | Director |
Jun 12 '25 |
Sale |
3.16 |
8,000 |
25,280 |
87,024 |
자본화:
|
볼륨(24시간):